MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 08-08-2025
Surmodics Depreciation & Amortization 2011-2026 | SRDX
Annual Depreciation & Amortization Surmodics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.69 M | 8.52 M | 9.14 M | 8.02 M | 7.26 M | 7.31 M | 6.43 M | 5.56 M | 4.87 M | 2.8 M | 2.72 M | 2.89 M | 2.93 M | 3.16 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 9.14 M | 2.72 M | 5.74 M |
Quarterly Depreciation & Amortization Surmodics
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.1 M | 2.14 M | 2.08 M | - | 2.13 M | 2.1 M | 2.33 M | - | 2.15 M | 2.09 M | 2.12 M | - | 2.21 M | 2.32 M | 2.38 M | - | 1.84 M | 1.91 M | 1.86 M | 5.39 M | 1.79 M | 1.86 M | 1.8 M | 5.46 M | 1.89 M | 1.8 M | 1.76 M | 4.71 M | 1.6 M | 1.76 M | 1.52 M | 4.01 M | 1.4 M | 1.52 M | 1.28 M | 3.7 M | 1.41 M | 1.28 M | 909 K | 2.08 M | 694 K | 909 K | 683 K | 2.05 M | 674 K | 683 K | 697 K | 2.17 M | 728 K | 697 K | 722 K | 2.21 M | 734 K | 722 K | 749 K | 2.39 M | 789 K | 749 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.46 M | 674 K | 1.85 M |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Bioventus
BVS
|
47 M | $ 8.9 | 0.39 % | $ 593 M |  USA |
 |
Castle Biosciences
CSTL
|
16 M | $ 26.04 | 0.81 % | $ 723 M | USA |
 |
Aspira Women's Health
AWH
|
264 K | - | -6.19 % | $ 10.5 M | USA |
 |
DexCom
DXCM
|
252 M | $ 68.33 | 2.99 % | $ 26.7 B | USA |
 |
Guardant Health
GH
|
39.7 M | $ 87.63 | 0.52 % | $ 11 B | USA |
 |
Charles River Laboratories International
CRL
|
403 M | $ 154.73 | 1.82 % | $ 7.67 B | USA |
 |
CareDx, Inc
CDNA
|
15 M | $ 17.59 | 1.56 % | $ 937 M | USA |
 |
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
IQVIA Holdings
IQV
|
1.14 B | $ 168.86 | 2.41 % | $ 29 B | USA |
 |
Exact Sciences Corporation
EXAS
|
125 M | $ 103.89 | 0.04 % | $ 19.6 B | USA |
 |
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M |  China |
 |
Fulgent Genetics
FLGT
|
24.9 M | $ 15.62 | 4.45 % | $ 472 M | USA |
|
Biodesix
BDSX
|
5.77 M | $ 16.88 | -2.37 % | $ 2.19 B | USA |
 |
ICON Public Limited Company
ICLR
|
488 M | $ 100.35 | 2.81 % | $ 8.28 B |  Irlanda |
 |
Anixa Biosciences
ANIX
|
38.3 K | $ 2.9 | 2.11 % | $ 94.1 K | USA |
 |
Danaher Corporation
DHR
|
750 M | $ 195.77 | 2.29 % | $ 140 B | USA |
 |
NeoGenomics
NEO
|
36.1 M | $ 8.36 | 1.46 % | $ 1.07 B | USA |
 |
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | USA |
 |
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | USA |
 |
Pacific Biosciences of California
PACB
|
13 M | $ 1.4 | 2.95 % | $ 420 M | USA |
 |
Illumina
ILMN
|
354 M | $ 121.89 | 2.18 % | $ 19.4 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
570 M | $ 198.82 | -0.06 % | $ 22.1 B | USA |
 |
QIAGEN N.V.
QGEN
|
203 M | - | - | $ 10.6 B |  Niderland |
 |
Agilent Technologies
A
|
321 M | $ 113.9 | 1.85 % | $ 34.6 B | USA |
 |
BioNano Genomics
BNGO
|
14 M | $ 1.12 | 0.9 % | $ 1.42 M | USA |
 |
DarioHealth Corp.
DRIO
|
473 K | $ 9.28 | 10.24 % | $ 263 M |  Israel |
 |
Neogen Corporation
NEOG
|
119 M | $ 9.32 | 2.25 % | $ 2.02 B | USA |
 |
Lantheus Holdings
LNTH
|
70.1 M | $ 78.96 | 0.59 % | $ 5.33 B | USA |
 |
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M | Israel |
 |
Co-Diagnostics
CODX
|
1.23 M | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Medpace Holdings
MEDP
|
27.2 M | $ 452.34 | -0.29 % | $ 13 B | USA |
 |
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
51.1 M | $ 1 219.76 | 1.76 % | $ 25.1 B |  Schweiz |
 |
Celcuity
CELC
|
130 K | $ 114.23 | -0.58 % | $ 4.51 B | USA |
 |
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | USA |
 |
Twist Bioscience Corporation
TWST
|
24.9 M | $ 46.61 | 3.55 % | $ 2.79 B | USA |
 |
National Research Corporation
NRC
|
7.62 M | $ 18.05 | 3.71 % | $ 404 M | USA |
 |
Invitae Corporation
NVTA
|
142 M | - | - | $ 21.2 M | USA |
 |
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
16.7 M | $ 199.84 | 1.09 % | $ 19.7 B | USA |